U.S. Self-amplifying Rna Synthesis Market Size & Outlook
Related Markets
U.S. self-amplifying rna synthesis market highlights
- The U.S. self-amplifying rna synthesis market generated a revenue of USD 45,095.7 thousand in 2024 and is expected to reach USD 117,485.7 thousand by 2030.
- The U.S. market is expected to grow at a CAGR of 17.5% from 2025 to 2030.
- In terms of segment, products was the largest revenue generating product & service in 2024.
- Custom Synthesis Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Self-amplifying rna synthesis market data book summary
| Market revenue in 2024 | USD 45,095.7 thousand |
| Market revenue in 2030 | USD 117,485.7 thousand |
| Growth rate | 17.5% (CAGR from 2025 to 2030) |
| Largest segment | Products |
| Fastest growing segment | Custom Synthesis Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD thousand |
| Market segmentation | Products, Custom Synthesis Services |
| Key market players worldwide | Genscript Biotech Corp Class H, Creative Biogene, OZ Biosciences, BOC Sciences, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, Applied DNA Sciences Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.0% of the global self-amplifying rna synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. self-amplifying rna synthesis market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 12,683.2 thousand by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Self-Amplifying RNA Synthesis Market Scope
Self-Amplifying RNA Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| OZ Biosciences | View profile | 11-50 | Marseille, Provence-Alpes-Cote d'Azur, France, Europe | http://www.ozbiosciences.com |
| Creative Biogene | View profile | 1-10 | Shirley, New York, United States, North America | http://www.creative-biogene.com |
| BOC Sciences | View profile | 501-1000 | Shirley, New York, United States, North America | https://www.bocsci.com/ |
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| Applied DNA Sciences Inc | View profile | 55 | 50 Health Sciences Drive, Stony Brook, New York, NY, United States, 11790 | https://www.adnas.com |
| Maravai LifeSciences Holdings Inc Ordinary Shares - Class A | View profile | 570 | 10770 Wateridge Circle, Suite 200, San Diego, CA, United States, 92121 | https://www.maravai.com |
U.S. self-amplifying rna synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to self-amplifying rna synthesis market will help companies and investors design strategic landscapes.
Products was the largest segment with a revenue share of 71.56% in 2024. Horizon Databook has segmented the U.S. self-amplifying rna synthesis market based on products, custom synthesis services covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. self-amplifying rna synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. self-amplifying rna synthesis market databook
-
Our clientele includes a mix of self-amplifying rna synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. self-amplifying rna synthesis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. self-amplifying rna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. self-amplifying rna synthesis market size, by product & service, 2018-2030 (US$K)
U.S. Self-Amplifying RNA Synthesis Market Outlook Share, 2024 & 2030 (US$K)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
